key: cord-0766776-j6p1ma2s
authors: Ishaq, Sonia Elia; Abdulqadir, Shang Ziyad; Khudhur, Zhikal Omar; Omar, Shwan Ali; Qadir, Mahdi Khaled; Awla, Harem Khdir; Rasul, Mohammed Fatih; Bapir, Ahmed Abdulrazzaq; Zanichelli, Anna; Mansoor, Muhammad Khalid; Kaleem, Muhammad; Rizwan, Muhammad Arif; Smail, Shukur Wasman; Babaei, Esmaeil
title: Comparative study of SARS-CoV-2 antibody titers between male and female COVID-19 patients living in Kurdistan region of Iraq
date: 2021-10-24
journal: Gene Rep
DOI: 10.1016/j.genrep.2021.101409
sha: 3c61d41ceae41ca8d923fe87a4dfb45750555294
doc_id: 766776
cord_uid: j6p1ma2s

Recently, there is increasing evidence that coronavirus disease 2019 (COVID-19) causes men to experience more serious symptoms and have a higher mortality rate than women, but the association between sex and immune response stays unknown till now, and weather patient’s prognosis associated with sex or not is another vague in COVID-19. In this study, the SARS-CoV-2-specific antibody titer test was performed for 727 patients who were a positive RT-PCR result for COVID-19 and we determined the difference in immune response in both genders. Patients were divided into two groups based on their genders, which were 383 males and 344 females. Plasma was collected from the patients after 17 days of diagnosis with COVID-19, and the concentrations of specific antibodies (IgG and IgM) was measured by multiparametric immunoassay system (VIDAS). Results demonstrated that there was no significant difference in both IgM and IgG production in male participants compared to women. Moreover, despite there was a weak significant positive association between age and IgM in male patients, while there was no significant correlation between IgG and age for the same gender. On the other hand, a slight positive correlation between IgM and IgG with age was observed in female participants. Finally, it concluded that there was no sex biases in patients with COVID-19 in Erbil, Iraq. So, these findings are crucial to treat and care male and female’s patients infected with COVID-19 at hospitals.

SARS-CoV-2, a type of novel coronavirus, was initially identified in November 2019 in several cases in China-Wuhan city (Zhu et al., 2020) . Later that, the World Health Organization (WHO) introduced outbreak of SARS-CoV-2 as a pandemic on March 11 th , 2020 . It has become increasingly evident that gender has relationship with disease severity in which Covid-19 develops in males with severe symptoms and high mortality rate. In England, a cohort study that includes 17 million adults declared that male sex is significantly associated with death risk by SARS-Cov-2 (hazard ratio 1.59, 95% CI 1.53-1.65) (Williamson et al., 2020) . About 60% of affected people died by worldwide were men (Gebhard et al., 2020) .

The higher incidence and higher mortality rate of COVID-19 in men compared to women is due to differences in biological factors (including differences in DNA, reproductive organs, and steroid hormones), and gendered-related issues such as practicing the traditional and social aspects (Gebhard et al., 2020) . Social aspects that have negative effects on health are more in men as compared to women such as smoking, drug and alcohol abuse (Griswold et al., 2018) . Men have higher age adjusted rates of coexistence of such diseases such as chronic obstructive pulmonary disease (COPD) which is obstruction of airflow from lungs and cardiovascular disease (CVD), both of them linking to a weak COVID 19 prognosis (Ozaslan et al., 2020; Junejo et al., 2020; Junejo et al., Previous researches demonstrated that sex could have a significant impact on infection outcomes and was linked to fundamental variations in immune responses to the diseases in human (Safdar et al., 2021; Fischer et al., 2015, Klein and Flanagan, 2016) . For example, men have a significantly higher prevalence of hepatitis A (a viral liver disease) and tuberculosis (a bacterial infection) than women (Guerra-Silveira and Abad-Franch, 2013). Moreover, the viral titter of human immunodeficiency virus (HIV) as well as hepatitis C virus (HCV) is considerably higher in male patients suffering from AIDS and HCV (Moore et al., 2003 , Collazos et al., 2007 . Females, conversely, react to vaccines with a greater immune response (Fink et al., 2018) . These results give a common idea that females could be more resistance and have high immunity against infectious agents.

Nevertheless, the exact mechanism of development of COVID-19 by SARS-CoV-2 in male patients with serious outcomes in comparison with female patients is still unclear.

Finding and identifying the antibodies against SARS-CoV-2 was applied for prevention, management and control program of COVID-19 (Zhejiang da et al., 2020) . Currently, the antibody is commonly used for patients to clinically diagnose COVId-19 in China (Zeng et al., 2020) . Antibody tests for IgM and IgG are positive in which both IgM and IgG are detected approximately 1 week after symptom onset (Xiang et al., 2020) . There is not effective treatment for COVID-19. In addition, it is observed that SARS-CoV-2 IgG has protective role against SARS-CoV-2. Accordingly, SARS-CoV-2 IgG isolated from patients recovered from severe COVID-19, transfers to recipient patients (Shen et al., 2020 , Ye et al., 2020 that could significantly neutralize the virus and mitigate the symptoms (Ye et al., 2020) . However, it is unknown if men and women patients with COVID -19 have different levels of SARS-CoV-2 IgG.

In this study, we aimed to figure out the immune responses of male and female patients against SARS-CoV-2 in Erbil, Iraq. In addition, we analyzed and assessed SARS-CoV-2 IgM and IgG levels following to the difference in sex in the context of immune phenotype.

All participants are COVID-19 patients who were admitted in Rizagari hospital, Erbil, 

GraphPad prism 6.0 was used for doing statistics and making graphs. The data were nonparametric since they did not obey the criteria of parametric data (they did not pass normality test of De-Agostino, Shapiro and Kolmogorov). The comparison of parameters between male and female group were done by Mann-Whitney U test while the correlation between them were done by spearmen correlation. The data are non-parametric and were represented by median and interquartile range (IQR). P-value less than 0.05 regarded as statistically significant.

We first examined age and titers of SARS-CoV-2 IgM antibodies between male and female groups. We found that the median and IQR of IgM antibodies in male group (0.290 (0.120-1.483)) had on average a non-significant difference (P-value=0.410) than the female group (0.570 (0.020-7.610)). The median of age was also showed nonsignificant change between two groups (43.00 (33.00-57.00) in male vs 42.00 (30.75-55.25) in the female). The titer of SARS-CoV-2 IgG antibodies were also comparable ( Fig. 2a ). We found that the median of IgG antibodies of male group (0.570 (0.020-7.610)) was also non-significantly differed than the IgG of female group (1.170 (0.020-7.720)) ( Table 2, Fig. 2b ).

The SARS-CoV-2 antibodies were also correlated with the age in both male and female group. The relation revealed that in male patients, levels of IgM antibody were weakly positively correlated with age (r =0.104, P =0.046) (Fig. 3a, Table 3 ), whereas there was no association between levels of IgG antibody and age (r =0.103, P =0.056) (Fig. 3b , Table 3 ). By contrast, in female patients, levels of IgM and IgG antibodies were weakly positively associated with higher age (r =0.137, P =0.011) (r =0.218, P < 0.0001) (Fig. 3c, 3d, Table 3 ).

CoV-2 were not significant statistically in our study. Secondly, the direct correlations between antibody production and age in female participants have been observed. There was also no correlation found between IgG and patients age in our population.

More importantly, IgG level in infected women is higher than in men, pretending why the survival rate and better patient's prognosis are higher in females (Zeng et al., 2020 , Xiang et al., 2020 . However, there were no significant differences in IgG level in both genders in our study. Our data was quite different from Kutsuna et al. (2021) results that showed men have a higher antibody titers concentration than women. Also, our finding was different from Robbiani et al. (2020) results, which found that antibody titers in men are lower than in women. Although this discrepancy could be affected by genetic bases and also non genetics local factors, finding the possible cellular and molecular mechanisms explaining the antibody outcome stays unknown and require further investigation.

Furthermore, according to one of the studies performed by Sarhan et al. (2020) in Iraq, in which its antibody level production was close to our participant, the survival rate in men is lower than in females. However, antibody production level may not be the only reason for having a higher death rate in men compared to women in our study but, it might be due to men having a worse lifestyle than women such as smoking and alcohol consumption (Griswold et al., 2018) . The presence of androgens and androgen receptors, higher expression of TMPRSS2 may be responsible for having a higher death rate in a male. TMPRSS2 are participating in SARS-CoV-2 infection combined with immunosuppressive effects of Androgens and comorbidities might have a role in the severity of the disease. On the other hand, a higher survival rate in women may be due to estrogens' protective function, which has a role in having more robust innate immune J o u r n a l P r e -p r o o f Journal Pre-proof response necessary for having a faster clearance of virus loads in female (Chakravarty et al., 2020) .

Even though the physiologic mechanisms explaining the relationship between antibody production and age in the Iraqi population stay unidentified, evidences provide that SARS-CoV-2-specific antibody responses can be different in numerous age categories such as children and adults compared to those who possibly tried various clinical manifestations (Weisberg et al., 2021) .

Although finding a similar immune response in infected male and female with COVID-19 in our population is a crucial results and demands further investigation to figure out the mechanism, limitations exist in analyses of this article should be considered. Firstly, samples from healthy individuals have been taken and used as a control. Secondly, viral RNA, cytokine and chemokine concentrations for our participants have not been measured.

In conclusion, our results demonstrated that there was no significant differences between men and females infected with COVID-19 in Erbil, Iraq, and this vital outcome clarified that a different therapeutic approach for male and female is not necessary. Furthermore, SARS-CoV-2 IgG and IgM antibody concentrations in our population are pretty similar in both males and females.

There are no conflicting interests declared by the authors. 

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies

Novel coronavirus (COVID-19) Outbreak in Iraq: The First Wave and Future Scenario

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

CoV-2 in children and adults across the COVID-19 clinical spectrum

Factors associated with COVID-19-related death using OpenSAFELY

Antibody detection and dynamic characteristics in patients with coronavirus disease

Treatment with convalescent plasma for COVID-19 patients in Wuhan

Antibodies in infants born to mothers with COVID-19 pneumonia

Handbook of COVID-19 prevention and treatment : the First Affiliated